Roche Molecular Systems??The company signed an interim working capital loan agreement with a major shareholder, who is also one of the firm's directors, it said in a statement. The one-year loan bears a 2 percent interest rate and is repayable on demand, secured against the firm's intellectual property. "The interim working capital financing announced today provides GeneNews sufficient capital to support continuing operations in the short-term," GeneNews Executive Chairman James Howard-Tripp said in a statement. The company said it will use the funds to restructure its operations, which "may include a strategic financing, sale, merger, or other business combination," though Howard-Tripp noted that "no decision has been made with regard to these alternatives, and there is no assurance that any transaction will be entered into or consummated." Any chance this director is "Heiner Dreismann" ??? This could get interesting.gltal